Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Jelinek Richard M

2. Date of Event Requiring Statement (MM/DD/YYYY) 5/19/2017

3. Issuer Name and Ticker or Trading Symbol

AETNA INC /PA/ [AET]

(Last) (First) (Middle)

AETNA INC., 151 FARMINGTON AVENUE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
EVP, Enterprise Strategy /

(Street)

HARTFORD, CT 06156

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Rights	11/2/2016	11/1/2025	Common Stock	16806 ⁽¹⁾	$115.34	D
Restricted Stock Units	11/2/2018	11/6/2018	Common Stock	26011 ⁽²⁾	⁽³⁾	D
Stock Appreciation Rights	2/19/2017	2/18/2026	Common Stock	81038 ⁽⁴⁾	$103.45	D
Stock Appreciation Rights	2/17/2018	2/16/2027	Common Stock	79938 ⁽⁵⁾	$125.27	D

Explanation of Responses:
(1)	Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") are exercisable in three annual installments beginning November 2, 2016.
(2)	Restricted Stock Units ("RSUs") granted under the Plan.
(3)	Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes.
(4)	SARs granted under the Plan are exercisable in three substantially equal annual intallments beginning February 19, 2017.
(5)	SARs granted under the Plan are exercisable in three annual installments beginning February 17, 2018.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Jelinek Richard M AETNA INC. 151 FARMINGTON AVENUE HARTFORD, CT 06156			EVP, Enterprise Strategy

Signatures
/s/ Richard M. Jelinek by Judith H. Jones, Attorney-in-Fact		5/25/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.